Our quality policy is to achieve customer satisfaction, through the development of a sustainable

Read More


APL has two manufacturing units with the latest state-of-the-art, most modern manufacturing

Read More

R & D

Our R & D is constantly focused on development of new molecules and efficiency improvement ....

Read More


To be recognized as a one of the leading Global manufacturers of Quality Active Pharmaceutical Ingredients and their Intermediates

Milestones :

  • Certificate of Suitability (COS) for Cetirizine Di HCl, Losartan Potassium & Fluconazole from EDQM during 2011.
  • Full scale commercialization of 3rd manufacturing block at Unit-II during calendar year 2011.
  • Full scale commercialization multipurpose 4th Manufacturing Block at Unit-II during the calendar year 2010
  • Audit & Approvals of Vizag Facility by South Korean FDA during Juluy’2009
  • Filing of DMF’s for APIs in Regulated and Semi Regulated Markets.
  • WHO GMP Certification of Unit-IIduring Dec’2008.
  • Auctus Pharma Pvt.Ltd converted into a Limited Company effective from 13th July,2007 and became Auctus Pharma Limited
  • Dr. Mohan, a Doctorate in Organic Chemistry joined as Director from 04.04.2007
  • Merger of Neo Medichem Pvt.Ltd has been merged into Auctus Pharma Limited by the Order of High Court dated.26.02.2008 effective from 01.04.2007.
  • ISO 9001:2000 Certification of NMPL on April, 2006 from AQA International LLC., USA.
  • WHO GMP Certification of NMPL in the month of September, 2004.
  • Acquisition of M/s.Sharp Organics Pvt.Ltd and re-naming as M/s.Auctus Pharma Pvt.Ltd in Aug’2003.
  • Acquisition of Neo Medichem Pvt Ltd (NMPL) in November, 2002